News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Iomab-B for the treatment of Refractory and Relapsed Acute Myeloid Leukaemia

Iomab-B is a radio-immunotherapeutic drug developed by Actinium Pharmaceuticals for treatment of refractory and relapsed acute myeloid...

Abaloparatide-SC for the Treatment of Post-menopausal Osteoporosis

Abaloparatide-SC is an injectable formulation of abaloparatide developed by Radius Health for the treatment of osteoporosis in...

Anthim (obiltoxaximab) Injection for the Treatment of Inhalational Anthrax

Anthim (obiltoxaximab) is an injectable drug developed by Elusys Therapeutics for the treatment of inhalational anthrax caused by...

March's top stories: Tracon's Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

Tracon Pharmaceuticals started Phase Ib clinical trial of TRC105, a clinical stage antibody to endoglin, and ADC Therapeutics began a...


Latest Suppliers

Kemwell
Kemwell has been providing CDMO services to pharmaceutical and biopharmaceutical clients globally for more than three decades. Kemwell scientists are specialists in dosage form...
See all suppliers

Latest Products & Services

Malvern Instruments
Viscotek UV Detector
Viscotek UV detector provides accurate measurements of the polymer or protein concentration profile that is essential to good molecular weight or structure data....
See all products

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115